The Infusion Blog

Blog articles are primarily written by voices of the infusion industry. The opinions of guest authors do not necessarily represent or reflect the opinions or positions of NICA. 

Biosimilars 101 for AIC Organizations
By: Michael Rigas, Pharm.D., FNHIA Biosimilars are also known as follow-on biologics or subsequent-entry biologics. They are FDA-approved copies of the original “innovator” drug product that are allowed to be licensed and approved by the FDA once the innovator product’s patent expires. The Biologics Price and Competition Act (BPCA) was introduced by Senator Edward Kennedy in 2007 and was passed by Congress and signed by President Obama in 2010 as part of the Patient Protection
Blog Operationalizing the Sales Process for an Independent Ambulatory Infusion Center
By: Ty Bello, BS, RCC The objective of this article is to provide information with application so you, as an Independent Ambulatory Infusion Center, can either begin the sales journey or accelerate the existing sales process in your business. So regardless of whether or not you have a sales team, this article will provide insight and information that can move the needle on your sales process and team. To approach this topic so broadly, we
IV Practice Pearls
By: Kay Coulter, RN, CRNI, VA-BC In the insurance industry there’s a saying about how you don’t know you’re facing litigation until it’s too late. Ambulatory Infusion Center providers can tell you risk management is key to protecting patients from harm and staff from lawsuits. IV Therapy Practice Pearls will offer current evidence-based principles, practice points and information related to the placement of peripheral vascular access devices, as well as the delivery of IV fluids
Blog Understanding the Recent Surge in Investment Interest in the Infusion Industry
What’s behind the recent surge of investments into the infusion industry? The ambulatory infusion center (AIC) industry has seen a significant surge in investment in recent years. This trend is driven by a number of factors, including an aging population, an increase in chronic diseases, and a shift towards more cost-effective, out-of-hospital care. What Is Private Equity? Private equity is a broad term which generally refers to private investment funds that make investments in privately
Unifying Prior Authorization Data
The following post was authored in partnership with NICA partner, SamaCare. Prior authorizations are a burden across all specialties. In fact, in a 2022 survey by SamaCare, 91% of providers reported that prior authorizations have a “highly negative” or “somewhat negative” effect on patient care. Infusion centers face their own unique set of challenges when it comes to navigating the complex prior authorization landscape.  To begin, infusion centers typically deal with a high volume of
Optimizing Your Ambulatory Infusion Center Schedule
As the number of Americans living with chronic illnesses continues to grow and payers move forward with site-of-care optimization policies, the demand for ambulatory infusion centers (AIC) has exploded.  AICs offer many advantages to patients and providers while delivering vital treatment options for patients with a wide range of conditions, from cancer to Crohn’s disease. Running an AIC, however,  is not without its challenges. One of the biggest challenges we often hear about from AIC
Utilizing Vein Visualization Devices In Independent Infusion Centers
When it comes to utilizing vein visualization devices in independent infusion centers picking the right device for your needs is key. While not all ambulatory infusion centers utilize vein visualization devices, if your center is looking to  optimize patient experience, reduce complications, and increase efficiency you may want to consider implementing vein visualization devices. To find out why, let’s explore a situation that happened to me as a new infusion nurse.  While completing my initial

Log in with your credentials

Forgot your details?